These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 963962

  • 21. The use of diuretics in preventing ascites recurrence.
    Arrigoni A, Andriulli A, Gindro T, Verme G.
    Br J Clin Pract; 1988 Mar; 42(3):116-20. PubMed ID: 3207572
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of the edemato-ascitic syndrome with an injectable aldosterone antagonist: 8109 CB].
    Dubarry JJ, Bancons J, Quinton A.
    Bord Med; 1971 Dec; 4(12):3751-7. PubMed ID: 5146181
    [No Abstract] [Full Text] [Related]

  • 23. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, Ceolotto G, Gatta A.
    Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
    [Abstract] [Full Text] [Related]

  • 24. [Results and therapeutic indications of a new diuretic: ethacrynic acid].
    Olmer M, Teule M.
    Sem Ther; 1967 Oct; 43(8):455-7. PubMed ID: 5623994
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload.
    Bissoli F, Gini G, Bosio M, Ceriani R.
    Recenti Prog Med; 1996 May; 87(5):227-8. PubMed ID: 8767760
    [No Abstract] [Full Text] [Related]

  • 28. [Preliminary clinical trials of ethacrynic acid in intravenous administration].
    Cicconetti C, Cantera N.
    Minerva Med; 1970 Apr 04; 61(27):1363-7. PubMed ID: 5439718
    [No Abstract] [Full Text] [Related]

  • 29. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB, Laragh JH.
    Circulation; 1968 Jan 04; 37(1):45-53. PubMed ID: 5634728
    [No Abstract] [Full Text] [Related]

  • 30. [Ethacrynic acid: research on the mechanism of action and clinical use].
    Zucchelli P, Petrella A, Fusaroli M, Sasdelli M, Melica A.
    Minerva Med; 1968 Jan 17; 59(5):129-45. PubMed ID: 5639119
    [No Abstract] [Full Text] [Related]

  • 31. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)].
    Capuani A, Bernabei M, Pasque A, Eufrate S.
    G Ital Cardiol; 1980 Jan 17; 10(9):1148-55. PubMed ID: 7461364
    [Abstract] [Full Text] [Related]

  • 32. [Changes in nitrogen balance during the period following abdominal surgery and use of an injectable anti-aldosterone].
    Metivier Y, Guinot P, Saizy R, Meillaud J, Lioret N.
    Agressologie; 1976 Jan 17; 17(5):313-8. PubMed ID: 1015551
    [No Abstract] [Full Text] [Related]

  • 33. Diuretics in edema: how they work; how to pick the best one.
    Cannon PJ.
    Med Times; 1972 Mar 17; 100(3):86-102. PubMed ID: 4559278
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV, Borghi C, Mussi A, Ambrosioni E.
    Minerva Cardioangiol; 1988 Oct 17; 36(10):503-7. PubMed ID: 3226562
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F, Ferraù O, Pitrone F, Luzza G, Russo A, Virga T.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract] [Full Text] [Related]

  • 38. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P, Fauvert R.
    Rev Int Hepatol; 1969 Dec 30; 19(4):241-51. PubMed ID: 5404532
    [No Abstract] [Full Text] [Related]

  • 39. Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
    Bolondi L, Piscaglia F, Gatta A, Salerno F, Bernardi M, Ascione A, Ferraù O, Sacerdoti D, Visentin S, Trevisani F, Mazzanti R, Donati G, Arena U, Gentilini P, DOC (Decrease Of Complications in cirrhosis) Study Group.
    Clin Gastroenterol Hepatol; 2006 Nov 30; 4(11):1395-402. PubMed ID: 16931172
    [Abstract] [Full Text] [Related]

  • 40. Clinical study of a new diuretic--ethacrynic acid.
    de Sousa RC, Jenny M.
    Helv Med Acta; 1967 May 30; 33(5):424-36. PubMed ID: 6038436
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.